Showing 113 news articles about PrEP science

Filters Content type: Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP science

Where Were the Women? Gender Parity in Clinical Trials

Editor's pick
New England Journal of Medicine (free registration required)
31 October 2019
PrEP science

Evaluating Microarray Patches for Long-Acting PrEP and Contraceptives

Editor's pick
Contagion Live
3 October 2019
Injectable & long-acting HIV treatment

HIV implant targets disease for up to a year

Editor's pick
The Engineer
26 September 2019
PrEP science

Long-acting injectable multi-drug implant shows promise for HIV prevention and treatment

Editor's pick
EurekAlert
23 September 2019
PrEP policies & guidelines

A New Oral PrEP Strategy Is On the Horizon, But Who’s Going to Get It?

Editor's pick
AVAC
29 August 2019
PrEP science

Gilead's Descovy AdCom gets 'controversial' as panelists split over use in women

Editor's pick
Fierce Pharma
8 August 2019
PrEP science

Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results

Editor's pick
TheBodyPro
3 August 2019
PrEP science

#IAS2019: PrEP implants could revolutionise HIV prevention

Editor's pick
Health-e
29 July 2019
PrEP science

Someday, an Arm Implant May Prevent H.I.V. Infection for a Year

Editor's pick
New York Times
24 July 2019
PrEP science

Trial Pairs PrEP With Behavioral Intervention to Prevent HIV in Drug Users

Editor's pick
Contagionlive.com
12 July 2019
PrEP science

CytoDyn Signs Groundbreaking Memorandum of Understanding with Thai Red Cross AIDS Research Centre to Study Pre-Exposure Prophylaxis Use of Leronlimab (PRO 140) in People at High Risk of Acquiring HIV

Editor's pick
CytoDyn press release
20 June 2019
PrEP science

Truvada as PrEP Tied to Only Modest Bone Density Decline

Editor's pick
POZ
17 June 2019
PrEP science

Study Suggests Widespread PrEP Use Would Take a Big Bite Out of HIV

Editor's pick
POZ
11 June 2019
PrEP policies & guidelines

Is Off-Label HIV Prevention Better Than None?

Editor's pick
MedPage Today (requires free registration)
31 May 2019
Global health targets

New Zealand: The tide turns on HIV

Editor's pick
Newsroom
17 May 2019
PrEP science

Some people may have genes that hamper a drug's HIV protection

Editor's pick
Science News
13 May 2019
Drug interactions & pharmacokinetics

Do Feminizing Hormones Impact Efficacy of PrEP Drugs?

Editor's pick
Contagion Live
29 April 2019
PrEP science

PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV

Editor's pick
American Journal of Managed Care
24 April 2019
PrEP science

Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

Editor's pick
Treatment Action Group
17 April 2019
PrEP science

Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

Editor's pick
The Body
9 April 2019
PrEP science

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

Editor's pick
Gilead press release
8 April 2019
PrEP science

Op Ed: On-Demand PrEP Strategies Work Despite Recent Contraction

Editor's pick
HIV Plus
30 March 2019
PrEP science

An Australian Doctor Has Some Answers About PrEP User With HIV

Editor's pick
HIV Plus
26 March 2019
PrEP policies & guidelines

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

Editor's pick
The Body
24 March 2019